Ledger.

CTO, Myricx

Dr Robin Carr

Coverage

Stories naming Dr Robin Carr. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

6 deals

Brandon Capital news

Index of the venture firm's portfolio updates: financing rounds for AdvanCell and ENA Respiratory, grant awards via incubator programs, two closes of Fund Six, board hires, and Myricx Bio's completed sale to Novartis.

Brandon Capital portfolio Tue 23 Mar 2021 AdvanCellBrandon CapitalENA RespiratoryPheon TherapeuticsAimmune TherapeuticsALK-Abello A/SAnchorage Capital GroupANDHealthAravaxAustralian GovernmentBrandon BioCatalystCatalYmCicada InnovationsCUREatorCUREator+DentericEBR SystemsGenesisCareGeorge MedicinesHostplusInvestment NSWLumonusMedical Research Future FundMemorial Sloan Kettering Cancer CenterMills & ReeveMirugenMyricxNovartisNRF CorporationNRG TherapeuticsOMass TherapeuticsQ-SeraRespirionTerumo CorporationViral Vector Manufacturing FacilityAtlas VentureBiointelect VenturerCSLForbionHESTAQIC VenturesWA GovernmentAndrew OxtobyCarsten HellmannDr Jonathan TobinMelissa FarisMerrick HowesMohit RawatDr Robin CarrZickie Lim

Also Brandon BioCatalyst portfolio·Brandon Capital portfolio·Uniseed·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Cut Through Venture·SmartCompany·AFR Technology·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily·Startup Daily·@AuManufacturing·finance.yahoo.com·enarespiratory.com·Mirage News·Forbes Australia·advancell.com.au·Forbes Australia·datapile.co·Dealroom·Forbes Australia·datapile.co·Biotech Dispatch·fundedstartupsdaily.com·fundedstartupsdaily.com·Forbes Australia

Seed $8.2m

Myricx Pharma Launches with £4.5M (AU$8.2M) Financing to Progress its Novel NMT inhibitors in Cancer

UK biotech Myricx Pharma launched with a £4.5 million seed round from Sofinnova Partners and Brandon Capital to advance its NMT-inhibitor cancer drug discovery work.

Brandon BioCatalyst portfolio Mon 16 Nov 2020 Myricx PharmaCharles ConsultantsGSKHeptaresMedical Research Commercialisation Fund (MRCF)PfizerBrandon Capital PartnersSofinnova PartnersDr Andrew BellProf Ed TateMaina BhamanDr Roberto SolariDr Robin CarrDr Stephen ThompsonSue Charles

Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio

Something wrong? Tell us